BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15777341)

  • 1. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia.
    Persson L; Söderquist B; Engervall P; Vikerfors T; Hansson LO; Tidefelt U
    Eur J Haematol; 2005 Apr; 74(4):297-303. PubMed ID: 15777341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
    Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
    Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
    Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
    Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
    Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
    Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
    J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.
    Vänskä M; Koivula I; Jantunen E; Hämäläinen S; Purhonen AK; Pulkki K; Juutilainen A
    Cytokine; 2012 Dec; 60(3):787-92. PubMed ID: 22902948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.
    García de Guadiana-Romualdo L; Español-Morales I; Cerezuela-Fuentes P; Consuegra-Sánchez L; Hernando-Holgado A; Esteban-Torrella P; Jiménez-Santos E; Viqueira-González M; de Béjar-Almira Á; Albaladejo-Otón MD
    Support Care Cancer; 2015 Jul; 23(7):2175-82. PubMed ID: 25564222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
    von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
    Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
    Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia.
    Jimeno A; García-Velasco A; del Val O; González-Billalabeitia E; Hernando S; Hernández R; Sánchez-Muñoz A; López-Martín A; Durán I; Robles L; Cortés-Funes H; Paz-Ares L
    Cancer; 2004 Jun; 100(11):2462-9. PubMed ID: 15160353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia].
    Fu Y; Jiang H; Li LX; Chen J; Zhang JL; Wang LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1296-300. PubMed ID: 24156453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients.
    Qu J; L X; Liu Y; Wang X
    Indian J Med Res; 2015 Mar; 141(3):315-21. PubMed ID: 25963492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever.
    Bilgir O; Bilgir F; Kebapcilar L; Bozkaya G; Çalan M; Kırbıyık H; Avci M; Sari İ; Yuksel A; Isikyakar T
    Transfus Apher Sci; 2012 Feb; 46(1):19-24. PubMed ID: 22079264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.
    Prat C; Sancho JM; Dominguez J; Xicoy B; Gimenez M; Ferra C; Blanco S; Lacoma A; Ribera JM; Ausina V
    Leuk Lymphoma; 2008 Sep; 49(9):1752-61. PubMed ID: 18661397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of procalcitonin in febrile neutropenic patients: review of the literature.
    Sakr Y; Sponholz C; Tuche F; Brunkhorst F; Reinhart K
    Infection; 2008 Oct; 36(5):396-407. PubMed ID: 18759057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.
    Ortega M; Rovira M; Filella X; Almela M; Puig de la Bellacasa J; Carreras E; Mensa J
    Br J Haematol; 2004 Aug; 126(3):372-6. PubMed ID: 15257709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.
    Fleischhack G; Kambeck I; Cipic D; Hasan C; Bode U
    Br J Haematol; 2000 Dec; 111(4):1093-102. PubMed ID: 11167745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia.
    Persson L; Engervall P; Magnuson A; Vikerfors T; Söderquist B; Hansson LO; Tidefelt U
    Scand J Infect Dis; 2004; 36(5):365-71. PubMed ID: 15287382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis.
    Riché FC; Cholley BP; Laisné MJ; Vicaut E; Panis YH; Lajeunie EJ; Boudiaf M; Valleur PD
    Surgery; 2003 Mar; 133(3):257-62. PubMed ID: 12660636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemia.
    Gac AC; Parienti JJ; Chantepie S; Fradin S; Le Coutour X; Leclercq R; Reman O
    Leuk Res; 2011 Oct; 35(10):1294-6. PubMed ID: 21831426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.